Additional studies are required to determine if C9orf72 ALS/FTD iPSC-MGs respond differently to diseased human brain synaptoneurosomes, which may contain specific signaling molecules necessary for microglia activation and elimination of synapses. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.